文献速递颈动脉与弓上血管

术前贫血与症状性颈动脉内膜切除术后死亡率相关

Preoperative anemia is associated with mortality after carotid endarterectomy in symptomatic patients.
PubMed 文献 · J Vasc Surg · 2017-08-16

本研究基于ACS NSQIP靶向血管模块2011-2015年数据,比较有无术前贫血(血细胞比容<36%)的颈动脉内膜切除术患者,按症状状态分层。结果显示,在症状性患者中贫血与30天死亡率升高独立相关(OR 3.1),且贫血与围术期输血存在显著交互作用;无症状患者中贫血与死亡率无关。

要点

  • 症状性颈动脉内膜切除患者中,术前贫血增加30天死亡风险(OR 3.1)。
  • 贫血的症状性患者若接受围术期输血,死亡风险进一步升高(OR 7.8)。
  • 无症状患者中贫血与30天死亡率无关,应避免为需术前输血的无症状患者行颈动脉内膜切除。

核心结论

  • 术前贫血是症状性颈动脉内膜切除术后30天死亡的危险因素,但在无症状患者中无此关联。
  • 贫血与围术期输血对症状性患者30天死亡率存在显著交互作用,输血者风险更高。
  • 需术前输血的无症状患者应审慎选择颈动脉内膜切除。

研究设计与样本

  • 回顾性队列研究,数据来自ACS NSQIP靶向血管模块2011-2015年颈动脉内膜切除患者,共16,068例。
  • 按术前贫血(血细胞比容<36%)和症状状态分层,采用多变量分析校正基线差异。
  • 主要结局为30天死亡率,模型中纳入贫血与围术期输血的交互项。

主要发现

  • 症状性患者6734例(42%),其中贫血1500例(22%);无症状患者9334例,贫血1935例(21%)。
  • 症状性患者中,贫血者30天死亡率2.5% vs 非贫血者0.7%(P < .001);校正后OR 3.1(95%CI 1.9-5.0,P < .001)。
  • 症状性患者中贫血与围术期输血交互作用显著(P = .004):输血者OR 7.8(95%CI 3.4-18.0,P < .001),未输血者OR 2.3(95%CI 1.4-3.9,P = .002)。
  • 无症状患者中,贫血者与非贫血者30天死亡率0.9% vs 0.6%(P = .2);校正后OR 1.0(95%CI 0.5-2.0,P = .9),交互作用P = .1。
  • 术前输血者30天死亡率高于未输血贫血者:症状性9.7% vs 2.5%(n=31,P = .04);无症状9.5% vs 0.9%(n=21,P = .02)。

临床怎么用

  • 对症状性颈动脉内膜切除候选患者,应评估并考虑术前贫血对30天死亡风险的增加作用。
  • 症状性贫血患者若需围术期输血,死亡风险显著增高,应优化围术期管理。
  • 无症状患者术前贫血不增加30天死亡风险,但需术前输血者应重新评估手术必要性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Preoperative anemia and blood transfusions are associated with worse outcomes after surgery. However, the impact of preoperative anemia and transfusions on outcomes after carotid endarterectomy (CEA) is unknown. METHODS: CEA patients from 2011 to 2015 in the American College of Surgeons National Surgical Quality Improvement Program Targeted Vascular module were compared by the presence of preoperative anemia (hematocrit <36%) after stratification by symptom status. Multivariable analysis accounted for differences in baseline characteristics. We included an interaction term in our multivariable model to assess whether the effect of anemia differed significantly between patients who received a perioperative transfusion and those who did not, with 30-day mortality as our primary outcome. RESULTS: Of 16,068 patients, 6734 (42%) were symptomatic, of whom 1500 (22%) had anemia. Of the 9334 asymptomatic patients, 1935 (21%) had anemia. Both symptomatic and asymptomatic anemic patients were more likely to be transfused perioperatively compared with nonanemic patients, with 7.0% vs 0.4%, and 5.8% vs 0.7% (both P < .001). Among symptomatic patients, those with anemia compared with those without had a higher rate of 30-day mortality (2.5% vs 0.7%; P < .001). After adjustment, anemic symptomatic patients had a higher 30-day mortality risk (odds ratio [OR], 3.1; 95% confidence interval [CI], 1.9-5.0; P < .001) compared with nonanemic symptomatic patients. In addition, in symptomatic patients, we found a significant interaction between anemia and perioperative transfusion on the outcome of 30-day mortality (P = .004), with a higher risk in perioperatively transfused symptomatic patients with anemia (OR, 7.8; 95% CI, 3.4-18.0; P < .001) than in symptomatic patients with anemia who did not receive a perioperative transfusion (OR, 2.3; 95% CI, 1.4-3.9; P = .002). In asymptomatic patients, anemic and nonanemic patients had comparable 30-day mortality rates (0.9% vs 0.6%; P = .2). After adjustment, anemia was not associated with 30-day mortality in asymptomatic patients (OR, 1.0; 95% CI, 0.5-2.0; P = .9), nor did we identify an interaction between anemia and perioperative transfusion in asymptomatic patients (P = .1). Patients who received a preoperative transfusion had a higher 30-day mortality rate than anemic patients not receiving preoperative transfusion in both symptomatic (n = 31, 9.7% vs 2.5%; P = .04) and asymptomatic patients (n = 21, 9.5% vs 0.9%; P = .02). CONCLUSIONS: Preoperative anemia is a risk factor for 30-day mortality after CEA in symptomatic patients but not in asymptomatic patients. These results should be factored into the selection of symptomatic patients for CEA and dissuade treatment of asymptomatic patients scheduled for CEA who need a preoperative transfusion.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Pothof AB, Bodewes TCF, O'Donnell TFX, et al. Preoperative anemia is associated with mortality after carotid endarterectomy in symptomatic patients. J Vasc Surg. 2017. PMID: 28822658. doi:10.1016/j.jvs.2017.05.114

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。